下载
Product Specification
【ProductName】

IDH3G Antibody Blocking Peptide

【Cat NO.】

K108955P-Ag

【Source】

Synthetic

【Storage】

Store at -20℃,2 years.Avoid freeze/thaw cycles.

【Appearance】

Lyophilized powder

【Swiss Prot】

P51553

【Gene ID】

3421

【Application】

Blocking Peptide of K108955P Antibody

【Purification】

HPLC

【Activity】

Not tested

【Note】

Please allow the product to equilibrate to room temperature in a dry environment before opening the packaging.

Background:

Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. NAD(+)-dependent isocitrate dehydrogenases catalyze the allosterically regulated rate-limiting step of the tricarboxylic acid cycle. Each isozyme is a heterotetramer that is composed of two alpha subunits, one beta subunit, and one gamma subunit. The protein encoded by this gene is the gamma subunit of one isozyme of NAD(+)-dependent isocitrate dehydrogenase. This gene is a candidate gene for periventricular heterotopia. Several alternatively spliced transcript variants of this gene have been described, but only s